OTC Ocumetics Technology Corp.

0.2621USD0.3750 CAD · TSXV+1.35%Mkt Cap: 34.09M USDP/E: —

Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. It develops expandable intraocular lenses to eliminate the need for corrective lenses primarily …

Key Statistics

Company
Market Cap34.09M USD
Enterprise Value37.72M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-3.76M USD
Revenue/Share—
Last Price0.2621 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINCA67577H1047
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-12.75
EV/Revenue—
P/S—
P/B-12.10
EPS (TTM)-0.03 USD
EPS (Forward)—
52W Range
0.24474% of range0.6641
52W High0.6641 USD
52W Low0.2447 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE136.24%
ROA-282.11%
ROIC-448.27%
ROCE—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.35M USD
CapEx (TTM)88.14K USD
FCF Margin—
FCF Yield-3.64%
Net Debt2.95M USD
Net Debt/EBITDA-1.00
Net Debt/FCF—
Balance Sheet
Debt/Equity-1.34
Current Ratio0.03
Quick Ratio0.02
Book Value/Sh-0.02 USD
Cash/Share0.0007 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.130.04M
Float82.22M
Insiders35.25%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short3.19K
Short (prev mo.)3.67K
Technical
SMA 500.2882 (-9.0%)
SMA 2000.3274 (-19.9%)
Beta0.26
S&P 52W Chg12.00%
Avg Vol (30d)23.44K
Avg Vol (10d)26.53K
Technical Indicators
RSI (14)39.3
MACD-0.0103
MACD Signal-0.0094
MACD Hist.-0.0009
BB Upper0.2881 USD
BB Middle0.2723 USD
BB Lower0.2564 USD
BB Width11.65%
ATR (14)0.0083 USD
Vol Ratio (20d)0.82x

About Ocumetics Technology (CVE: OTC)

›

Ocumetics Technology (CVE: OTC) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector.

The shares were at 0.3750 CAD on 19 November 2026, down 60.1% over 52 weeks. Its 52-week range is 0.3500 CAD to 0.9500 CAD: the price is 60.5% below the high and 7.1% above the low.

Its market capitalisation is 48.76M CAD.

Ocumetics Technology reports return on equity of 136.2% and an operating margin of 0.0%.

Its debt exceeds its cash by 4.22M CAD. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health. The next earnings report is expected on 24 November 2026.